72 Investment Holdings’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.1M Hold
65,933
44.18% 1
2026
Q1
$21.2M Hold
65,933
42.83% 1
2025
Q4
$19.4M Hold
65,933
38.42% 1
2025
Q3
$3.49M Hold
65,933
5.14% 3
2025
Q2
$2.77M Hold
65,933
7.23% 3
2025
Q1
$2.5M Hold
65,933
7.02% 3
2024
Q4
$5.07M Hold
65,933
10.33% 3
2024
Q3
$3.79M Hold
65,933
8.16% 4
2024
Q2
$2.73M Hold
65,933
6.85% 4
2024
Q1
$4.02M Hold
65,933
6% 4
2023
Q4
$1.47M Hold
65,933
6.52% 4
2023
Q3
$1.69M Hold
65,933
11.33% 4
2023
Q2
$1.14M Hold
65,933
8.86% 4
2023
Q1
$800K Hold
65,933
0.38% 5
2022
Q4
$2.35M Hold
65,933
1.08% 4
2022
Q3
$2.25M Hold
65,933
1.78% 4
2022
Q2
$2.42M Hold
65,933
3.74% 4
2022
Q1
$10.1M Hold
65,933
11.05% 2
2021
Q4
$19.5M Hold
65,933
17.29% 2
2021
Q3
$18.3M Hold
65,933
22.84% 2
2021
Q2
$18.1M Hold
65,933
28.49% 2
2021
Q1
$32.4M Hold
65,933
48.98% 2
2020
Q4
$54.4M Buy
+65,933
New +$38.5M 7.33% 2

Other funds holding PRAX

72 Investment Holdings's PRAX Position: Q2 2026 in Review

72 Investment Holdings held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 65,933 shares worth $22.1M. The position accounts for 44.18% of the portfolio, ranked #1.

72 Investment Holdings first reported a position in PRAX in Q4 2020 and has held it in 23 quarters since. The position peaked at $54.4M in Q4 2020. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • 72 Investment Holdings held 65,933 shares of Praxis Precision Medicines worth $22.1M as of Q2 2026.
  • 72 Investment Holdings left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up 44.18% of 72 Investment Holdings's portfolio in Q2 2026, its #1 holding.
  • 72 Investment Holdings first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 23 quarters since.
  • 72 Investment Holdings's Praxis Precision Medicines position peaked at $54.4M in Q4 2020.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on 72 Investment Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.